Navigation Links
Geneticist Mary-Claire King receives the 2013 Paul Ehrlich Prize
Date:3/14/2013

Genes for hereditary breast cancer

Mary-Claire King has investigated the genetic predisposition for cancer intensively since 1974. She has shown that breast cancer and ovarian cancer are inherited as an autosomal dominant trait. Some of the mutations responsible are to be found in a gene that King called BRCA1, which stands for breast cancer susceptibility gene 1. She first demonstrated the connection by means of statistical analysis, later through linkage analysis, and finally by allocating the gene to a specific chromosome. In 1990 King published the approximate position of the BRCA1 gene in the human genome: position 17q21. Afterwards, there was a neck-and-neck race to clone the gene, a race that Myriad Genetics ultimately won in 1994. King later presented the complete sequence of the BRCA1 locus with 84 kilobases.

BRCA1 and the BRCA2 gene, which was identified later, are tumor suppressor genes. The corresponding proteins have the task of ensuring the stability of the DNA and preventing uncontrolled growth. Carriers of these mutations have a higher risk in life for breast and ovarian cancer. BRCA mutations account for some five to ten percent of all breast cancers and ten to fifteen percent of all ovarian cancers. King also calculated the exact disease risk. "In severe mutations, the risk is 80 percent for breast cancer and 40 percent for ovarian cancer," says the geneticist. "In other words, 800 out of 1000 women with severe BRCA mutations are likely to develop breast cancer during their lifetime, and 400 out of 1000 women with severe BRCA mutations can be expected to develop ovarian cancer during their lifetime. The figures for the general population are 120 out of 1000 women who will develop breast cancer and 10 out of 1000 women who will have ovarian cancer," King explains. Professor King also developed new methods for the genetic diagnosis of these and other breast cancer mutations, though their commercial use in the USA is blocked by the
'/>"/>

Contact: Dr. Hildegard Kaulen
Paul-Ehrlich-Stiftung@pvw.uni-frankfurt.de
49-612-252-718
Goethe University Frankfurt
Source:Eurekalert  

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Case Western Reserve receives Helmsley Trust grant to develop new glucose-sensitive insulin
2. Max Planck Florida Institute for Neuroscience receives new grant funding
3. Brain researcher James Poulet receives the 2013 Paul Ehrlich Prize for Young Researchers
4. GW researcher receives federal grant to study hedgehog regulation of cell-cell interaction
5. Platypus Australia’s Sun Safe & UV Protective Swimwear For Children Receives 4-Star Product Reviews At Online Community Family Capers
6. MIT student inventor Nikolai Begg receives Lemelson-MIT Student Prize
7. Fitness Revolution Receives Franchise Business Review’s Best in Fitness Franchisee Satisfaction Award
8. Controversial Labiaplasty Procedure Receives High Satisfaction Reviews From Patients
9. Einstein receives $3 million to study impact of soccer heading on the brain
10. DNDi receives BBVA Foundation award for delivering new treatments for neglected diseases
11. Cleveland Clinic researcher receives grant to fund autism research
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Geneticist Mary-Claire King receives the 2013 Paul Ehrlich Prize
(Date:12/26/2014)... 2014 DW-InductionHeating.com (DaWei Induction Heating Co.) ... and developing, producing and marketing of a series of ... announces their new series of induction brazing equipments ... company, induction brazing refers to the joining ... material and heat. The manager says that there are ...
(Date:12/25/2014)... 26, 2014 The report “Nintedanib ... 2023” focuses on the current treatment landscape, unmet ... colorectal cancer market. Stivarga is a drug which ... rectal cancer. Boehringer Ingelheim is developing nintedanib (BIBF-1120), ... of refractory CRC in the US, Europe, and ...
(Date:12/25/2014)... Recently, Dylan Queen, a famous online company supplying women’s ... discounted prom dresses, most of which are priced under ... company, the promotion is valid until Jan. 22, 2015; ... UK market. , The prom dresses in this new ... A-line strapless, empire strapless chiffon, one shoulder, floor-length, V-neck ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 When head lice ... themselves in a frenzy to get rid of it while ... families in Coral Gables now have the solution right in ... salon clinic location, Lice Troopers provides full spectrum head lice ... Coral Gable area, including Sunset, Key Biscayne, Brickell, Coconut Grove, ...
(Date:12/25/2014)... 2014 (HealthDay News) -- Among early stage breast cancer ... half of one percent will eventually develop leukemia as ... The finding comes from a review of more ... 2007, and it suggests that the risk for developing ... had previously thought. "The frequency of bone marrow ...
Breaking Medicine News(10 mins):Health News:Induction Brazing Equipment Series From DaWei Induction Heating Co., A Reliable Supplier Of Induction Heating Equipment 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3
... it has received approval from the U.S. Food and ... gum USP, 2 mg (coated fruit) and 4 mg ... marketed under store brand labels and is comparable to ... aid to smoking cessation. "This first store brand approval ...
... the advent of a possible new blockbuster drug and ... and drug addictions, global sales of smoking cessation and ... of little over $1.1 billion in 2005 to more ... and Addiction Treatments: A World Market Analysis, a new ...
... of mobile phones in the provision of clinical care are ... and Safety in Health Care argues. ,Healthcare ... to help improve the provision of care to people with ... disease. ,The UK and the US are leading ...
... Medarex, Inc. today announced a collaborative research agreement ... Chemical Holdings Corporation . The two companies expect ... against a Mitsubishi target for the potential treatment ... Medarex's UltiMAb Human Antibody Development System(R) to generate ...
... the most common addiction all over the world, and a ... impact of tobacco in its various forms on human health, ... smoking. ,Tobacco generates about Rs.7,964 crore ... about Rs.27,661 crore, according to WHO estimates. ...
... risk the wrath of the country's 350 million smokers today by ... ,"It will be applied in all Olympic venues and ... ,A sign of the passions the issue can raise ... ,Earlier this month, an attempt by security guards ...
Cached Medicine News:Health News:Perrigo Receives FDA Approval to Market Coated Fruit Nicotine Gum 2Health News:Urgent Need for Guidance on Mobile Phone Use in Clinical Care 2Health News:Tobacco Menace and What can Be Done About It 2Health News:Tobacco Menace and What can Be Done About It 3Health News:Tobacco Menace and What can Be Done About It 4Health News:China Bans Smoking at Olympics 2
(Date:12/24/2014)... Dec. 23, 2014 Echo Therapeutics, Inc. ... company focused on skin permeation, continuous glucose monitoring ... W. Hollander has been appointed Chief Executive ... more than 20 years of experience in the ... most recently served as Vice President, Business Development, ...
(Date:12/24/2014)... , Dec. 23, 2014 ResMed (NYSE: ... patent infringement action against Chinese medical device manufacturer BMC Medical ... ruled today that BMC,s masks listed below infringe ResMed,s patents, ... selling these masks in the United States ... N2 nasal mask , Willow nasal pillows mask ...
(Date:12/24/2014)... 23, 2014   Synageva BioPharma Corp. ... developing therapeutic products for rare disorders, today announced ... the Marketing Authorization Application (MAA) for sebelipase alfa ... company,s request for accelerated assessment, which has the ... The MAA, and the Biologics ...
Breaking Medicine Technology:Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 2Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 3ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 3
... AMRI (NASDAQ: AMRI ), a leading ... appointment of Ian Shott as President of AMRI Europe, ... In this newly created role, Mr. Shott will have ... company,s site in Wales, United Kingdom, and work closely ...
... SALT LAKE CITY, May 22, 2012   USANA Health ... global nutritional supplement company, today announced the promotion of ... and development and Dr. Brian Dixon to executive director ... Steely, a licensed naturopathic physician, Mark Levy, a Ph.D. ...
Cached Medicine Technology:AMRI Announces President for AMRI Europe 2AMRI Announces President for AMRI Europe 3USANA Health Sciences Expands Award-Winning Research and Development Team 2USANA Health Sciences Expands Award-Winning Research and Development Team 3